Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,273 | -21,813 | -73,764 | -55,417 | -37,424 |
| Depreciation Amortization | 84 | 49 | 176 | 171 | 120 |
| Other Working Capital | 608 | 2,836 | 6,818 | 1,802 | -1,737 |
| Other Operating Activity | 6,185 | 3,601 | 14,569 | 14,045 | 11,186 |
| Operating Cash Flow | $-34,396 | $-15,327 | $-52,201 | $-39,399 | $-27,855 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,220 | 6,478 | -27,455 | -28,626 | -33,590 |
| PPE Investments | -2,748 | -2,511 | -7,582 | -4,326 | -1,798 |
| Purchase Of Investment | -2,329 | -2,019 | -16,677 | -11,896 | -7,822 |
| Sale Of Investment | 2 | 1 | 5 | 4 | 4 |
| Other Investing Activity | 0 | 0 | -219 | -204 | -118 |
| Investing Cash Flow | $10,145 | $1,949 | $-51,928 | $-45,048 | $-43,324 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 203 | 183 | 84,685 | 84,177 | 84,057 |
| Common Stock Repurchased | -268 | -70 | N/A | N/A | N/A |
| Financing Cash Flow | $-65 | $113 | $84,685 | $84,177 | $84,057 |
| Beginning Cash Position | 48,736 | 48,736 | 68,175 | 68,175 | 68,175 |
| End Cash Position | 24,420 | 35,471 | 48,736 | 67,910 | 81,058 |
| Net Cash Flow | $-24,316 | $-13,265 | $-19,439 | $-265 | $12,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,396 | -15,327 | -52,201 | -39,399 | -27,855 |
| Capital Expenditure | -2,763 | -2,511 | -7,582 | -4,326 | -1,798 |
| Free Cash Flow | -37,159 | -17,838 | -59,783 | -43,725 | -29,653 |